Figure 3From: High EGFR copy number predicts benefits from tyrosine kinase inhibitor treatment for non-small cell lung cancer patients with wild-type EGFR Kaplan-Meier curves for PFS (A) and OS (B) by analysis of epidermal growth factor receptor (EGFR) amplification, high copy number and low copy number in wild-type EGFR. Back to article page